Pharmacists Perspective

 
 

  • Sep 17 2021 This Week in Cardiology   Cardiac arrest care, finerenone, carotids, meds post TAVI: less is more and the new may not be as grand as the tried and true. John Mandrola, MD, provides a third ESC review.
  • What Can You Do About AF in Primary Care?   The latest evidence on the prevention and management of atrial fibrillation provides guidance to primary care clinicians.
  • Bloating and Distention: How to Manage These Common Complaints   Dr David Johnson shares with clinicians the tools to diagnose and treat these frustrating symptoms.
  • New Single-Swab Test for COVID-19, Flu, and Respiratory Viruses   WebMD's Chief Medical Officer, John Whyte, MD, speaks with Brian Caveney, MD, President & Chief Medical Officer, Labcorp Diagnostics, about a new EUA test that can differentiate between COVID-19, the flu, and respiratory syncytial virus (RSV).
  • A Leading Virologist Reveals His Two 'Nightmare' Viruses   Virologist Florian Krammer talks about how much we should worry about the Delta virus and the truth about antibody tests.
  • Managing Symptoms of Long COVID   WebMD's Chief Medical Officer, John Whyte, MD, MPH, speaks with Janna Friedly, MD, MPH, a professor of physical medicine and rehabilitation at the University of Washington, about managing the symptoms of long COVID and her personal journey of recovery.
  • Statin Myalgia: Stop, Restart, or Switch? A 66-year-old woman is discharged from the hospital after an MI. At a follow-up appointment, she says she has muscle pain and stiffness in her legs and back. Which treatment would you recommend?
  • Early Cancer Drug Results: Are We Celebrating Too Soon? How we can spot limitations in new clinical trial findings.
  • Have We Set Unrealistic Goals for the End of the Pandemic?   WebMD's Chief Medical Officer, John Whyte, MD, speaks with Celine Gounder, MD, Infectious Disease Specialist, NYU Grossman School of Medicine, about her recent article in The Atlantic on how the pandemic is likely to end.
  • Could Fluvoxamine Work as COVID Treatment?   An old drug may be joining the COVID treatment arsenal. A new trial suggests that fluvoxamine reduces the severity of COVID-19 illness.
  • Regeneron Co-Founder on Monoclonal Antibody Treatment   WebMD's Chief Medical Officer, John Whyte, MD, speaks with George Yancopoulos, MD, PhD, President & Chief Scientific Officer, Regeneron Pharmaceuticals Inc., about the development and promise of monoclonal antibody treatment.
  • A Woman With Fatigue, Palpitations, and Headache A previously healthy 34-year-old woman reports with fatigue, palpitations, headache, dyspnea, and difficulty sleeping. What's your diagnosis?
  • FDA on COVID-19 Vaccines for Kids, Boosters, and Treatments   WebMD's Chief Medical Officer, John Whyte, MD, speaks with Janet Woodcock, MD, Acting Commissioner, FDA, about the latest COVID-19 developments including the status of vaccines for kids, booster shots, and treatments.
  • Testing for COVID-19 at Home   WebMD's Chief Medical Officer, John Whyte, MD, speaks with Sean Parsons, MD, CEO & Founder, Ellume Health, about various COVID-19 testing methods and when to consider using an antigen rapid test at home.
  • A Horse in the Hospital? Meet 'Doctor Peyo' A 15-year-old stallion is having a remarkable impact on the patients and caregivers at one French hospital.
  • 'Coma' Author Robin Cook on Medical Thrillers and Healthcare   With his latest book, 'Viral,' Robin Cook says he's trying to entertain people and get them to think about the parts of healthcare that aren't working.
  • ESC 2021 Lessons on AF Screening From the LOOP Study Screening for AF with an implantable monitor was not associated with lower stroke or systemic embolism overall, but the AF threshold was low and usual care was excellent, notes John Mandrola, MD.
  • Should Magnesium Be Used for COPD Exacerbations? Dr Holley reviews whether magnesium is beneficial or harmful when treating acute exacerbations of COPD in an emergency setting.
  • ESC 2021 Incremental, Not Monumental, Win for Empagliflozin in HFpEF The modest effects compel clinicians to be selective in the use of this costly drug, but there will be subgroups of patients who may benefit more, says John Mandrola, MD.
  • Aug 27 2021 This Week in Cardiology   COVID-19, NEJM vaccine safety paper, full-dose anticoagulation in COVID-19, AF and Exercise, and early results on EMPEROR -Preserved are the studies John Mandrola, MD, discusses in this week’s podcast.